Home
Conditions
Untreated Metastatic Squamous Neck Cancer With Occult Primary

Clinical trial condition

Untreated Metastatic Squamous Neck Cancer With Occult Primary

Explore clinical trials studying Untreated Metastatic Squamous Neck Cancer With Occult Primary. Study availability and eligibility vary by location and protocol.

13 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Untreated Metastatic Squamous Neck Cancer With Occult Primary trial results

Completed

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

NCT00939627

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

Suburban Hospital Bethesda, Maryland, United States

View Trial Details

Completed

Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer

NCT02245100

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +50 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT02035527

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +50 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

NCT01316757

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +35 more
Locations: Univesity of Rochester Medical Center Rochester, New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

NCT00101348

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +122 more
Locations: Cancer Therapy and Research Center at The UT Health Science Center at San Antonio San Antonio, Texas, United States

View Trial Details

Completed

Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

NCT00049283

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +37 more
Locations: Case Western Reserve University Cleveland, Ohio, United States

View Trial Details

Completed

Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

NCT00098631

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +21 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

NCT00031681

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Adult Primary Liver Cancer, +182 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00089362

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +142 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00096512

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
Locations: Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States

View Trial Details

Untreated Metastatic Squamous Neck Cancer With Occult Primary

Untreated Metastatic Squamous Neck Cancer With Occult Primary trial results

Related conditions